Trulieve Cannabis Corp. (TCNNF) officer settles RSU tax with 18,359 shares

Rhea-AI Filing Summary

Trulieve Cannabis Corp. reported an insider equity transaction by its Chief Production Officer on a Form 4. On December 1, 2025, 18,359 subordinate voting shares were withheld at a price of $5.39 per share to cover tax obligations arising from the vesting of previously granted restricted stock units. After this tax‑withholding event, the reporting person beneficially owned 200,182 subordinate voting shares directly. This filing reflects routine equity compensation and related tax settlement rather than an open-market purchase or sale.

Insider Trade Summary

Net Seller: 18,359 shares

Net Sell 1 txn

Insider Landrum Kyle

Role Chief Production Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Subordinate Voting Shares	18,359	$5.39	$99K

Holdings After Transaction: Subordinate Voting Shares — 200,182 shares (Direct)

Footnotes (1)

1. F1. Represents shares withheld for payment of tax liability in connection with vesting of restricted stock units ("RSUs") on December 1, 2025, the grant of which RSUs to the reporting person were previously reported on Form 4.

FAQ

What insider transaction did Trulieve Cannabis Corp. (TCNNF) disclose in this Form 4?

The filing reports that the Chief Production Officer had 18,359 subordinate voting shares withheld on December 1, 2025 to satisfy tax liabilities from vesting restricted stock units.

Was the Trulieve (TCNNF) Form 4 transaction an open-market trade?

No. The 18,359 shares were withheld for tax payment in connection with the vesting of restricted stock units, rather than bought or sold in the open market.

How many Trulieve (TCNNF) shares does the reporting person own after this transaction?

Following the reported tax-withholding transaction, the reporting person directly beneficially owned 200,182 subordinate voting shares of Trulieve Cannabis Corp.

What is the reported price per share in the Trulieve (TCNNF) Form 4?

The Form 4 lists a transaction price of $5.39 per subordinate voting share for the 18,359 shares withheld to cover tax obligations.

Who is the insider named in this Trulieve Cannabis Corp. (TCNNF) Form 4 and what is their role?

The reporting person is identified as an officer of Trulieve Cannabis Corp., holding the title of Chief Production Officer and filing as a single reporting person.

What explains the share withholding noted in the Trulieve (TCNNF) Form 4?

The explanation states that the shares represent withholding for payment of tax liability tied to the vesting of previously granted restricted stock units (RSUs) on December 1, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 12/08/2025 - 04:53 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Landrum Kyle

(Last) (First) (Middle)

C/O TRULIEVE CANNABIS CORP.

6749 BEN BOSTIC ROAD

(Street)

QUINCY FL 32351

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Trulieve Cannabis Corp. [ TRUL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Production Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Subordinate Voting Shares	12/01/2025		F		18,359(1)	D	$5.39	200,182	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld for payment of tax liability in connection with vesting of restricted stock units ("RSUs") on December 1, 2025, the grant of which RSUs to the reporting person were previously reported on Form 4.

	/s/ Eric Powers, as Attorney-in-Fact	12/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.